| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |